Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No "Cert"-ainty On Reverse Settlements: Supreme Court Declines To Take Up Case

This article was originally published in The Pink Sheet Daily

Executive Summary

Lower courts had found Bayer’s agreement with Barr and Hoechst to delay generic Cipro to be lawful; Second Circuit is to rule on the deal.

You may also be interested in...



Reverse Settlements Are Acceptable Under Certain Conditions, DoJ Says

Brand company payments to generic firms to settle infringement suits may not violate antitrust laws if they permit some competition, Department of Justice concludes.

Reverse Settlements Are Acceptable Under Certain Conditions, DoJ Says

Brand company payments to generic firms to settle infringement suits may not violate antitrust laws if they permit some competition, Department of Justice concludes.

FTC's Health Care Reform Plan: Save $12 Billion With Reverse Settlement Ban

The Federal Trade Commission has drawn another arrow in its attempt to shoot down reverse settlements between brand and generic drug companies - offering an estimate of $12 billion in government savings over the next 10 years from ending the practice

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS069594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel